BI 836845, Anti-Human IGF1 and IGF2 Recombinant Antibody
Xentuzumab (Anti-Human IGF1 and IGF2 Recombinant Antibody, BI836845) is a recombinant a human monoclonal antibody that targets IGF ligands IGF1 and IGF2. Xentuzumab inhibits both of IGF1 and IGF2 growth-promoting signalling and suppresses AKT activation[1].
Molecular Weight:
(143.7 kDa)
Purity:
99.71
CAS Number:
[1417158-65-6]
Target:
IGF-1R
Application Notes:
MCE Product type: Inhibitory Antibodies
* VAT and and shipping costs not included. Errors and price changes excepted